Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds HC Wainwright & Co. Reiterates Buy on Context Therapeutics, Maintains $4 Price Target

HC Wainwright & Co. Reiterates Buy on Context Therapeutics, Maintains $4 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates Context Therapeutics (NASDAQ:CNTX) with a Buy and maintains $4 price target.

February 7, 2023

1 minute read

HC Wainwright & Co. analyst Emily Bodnar reiterates Context Therapeutics (NASDAQ:CNTX) with a Buy and maintains $4 price target.

Trump’s $3M Attorney Chris Kise Sidelined From Mar-A-Lago Probe: Report

September 28, 12:41 AM

Former President Donald Trump’s attorney, Chris Kise, has been sidelined in the Mar-a-Lago documents case, according to a report.

May 12, 3:01 PM

Over the past 3 months, 21 analysts have published their opinion on Estee Lauder Cos (NYSE:EL) stock. These…

April 14, 8:12 AM

The most overbought stocks in the financial sector presents an opportunity to go short on these overvalued companies.

November 2, 9:20 AM

Entegris, Inc (NASDAQ:ENTG) reported third-quarter FY22 sales growth of 71% year-on-year to $993.8 million, missing the consensus of $1.02 billion.…